Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS methylphenidate dose-response study in adults with ADHD
2004-000730-37Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (5 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Primary efficacy endpoint. Started Dec 2004; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2004-000730-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000730-37.